Remo Guerrini Selected Research

Nphe(1)- (pF)Phe(4)- Aib(7)- Arg(14)- Lys(15)- nociceptin-amide

11/2015	Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity.
1/2010	Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Remo Guerrini Research Topics

Disease

11	Pain (Aches) 01/2021 - 02/2002
7	Neoplasms (Cancer) 01/2022 - 08/2011
6	Ovarian Neoplasms (Ovarian Cancer) 09/2019 - 08/2011
4	Substance-Related Disorders (Drug Abuse) 01/2021 - 09/2010
4	Hypotension (Low Blood Pressure) 11/2016 - 04/2003
3	Respiratory Hypersensitivity 04/2016 - 02/2010
3	Parkinson Disease (Parkinson's Disease) 06/2014 - 10/2005
3	Tics (Tic) 07/2004 - 01/2002
2	Cough 01/2021 - 03/2005
2	Overactive Urinary Bladder (Overactive Bladder) 01/2019 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 11/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013 - 08/2012
2	Sepsis (Septicemia) 01/2013 - 12/2008
2	Inflammation (Inflammations) 01/2013 - 11/2007
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2012 - 09/2005
2	Alcoholism (Alcohol Abuse) 11/2006 - 01/2002
2	Parkinsonian Disorders (Parkinsonism) 10/2005 - 12/2004
2	Bradycardia 08/2005 - 04/2003
1	Erectile Dysfunction 01/2022
1	Cognitive Dysfunction 11/2021
1	Dementia (Dementias) 11/2021
1	Melanoma (Melanoma, Malignant) 05/2021
1	Infections 05/2021
1	Hemoglobinopathies 10/2020
1	Thalassemia 10/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 10/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Isolated Systolic Hypertension 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Personality Disorders (Personality Disorder) 01/2019
1	Mental Disorders (Mental Disorder) 03/2017
1	Chronic Pain 01/2017
1	Anhedonia 01/2017
1	Asthma (Bronchial Asthma) 04/2016
1	Neurogenic Inflammation 04/2016
1	Neuralgia (Stump Neuralgia) 11/2015
1	Hypersensitivity (Allergy) 11/2015
1	Breast Neoplasms (Breast Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

15	NociceptinIBA 01/2021 - 02/2002
12	Peptides (Polypeptides)IBA 01/2021 - 11/2002
9	Proteins (Proteins, Gene)FDA Link 11/2014 - 11/2002
8	Biological ProductsIBA 01/2021 - 09/2010
7	NeuropeptidesIBA 01/2021 - 10/2005
7	LigandsIBA 03/2017 - 01/2002
6	Thymidylate SynthaseIBA 01/2021 - 08/2011
5	(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)IBA 01/2017 - 05/2005
4	Pharmaceutical PreparationsIBA 09/2019 - 06/2014
4	Anti-Anxiety Agents (Anxiolytics)IBA 03/2017 - 12/2008
3	EnzymesIBA 01/2022 - 08/2011
3	Nociceptin ReceptorIBA 01/2021 - 11/2006
3	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 11/2015
3	Oxidopamine (6 Hydroxydopamine)IBA 06/2014 - 10/2005
3	Opioid Analgesics (Opioids)IBA 01/2013 - 02/2002
3	Capsaicin (Zostrix)FDA Link 02/2010 - 03/2005
2	Growth InhibitorsIBA 09/2019 - 12/2014
2	PlatinumIBA 09/2019 - 08/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 11/2002
2	Analgesics (Analgesic Drugs)IBA 03/2017 - 08/2016
2	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017 - 08/2016
2	Morphine (MS Contin)FDA LinkGeneric 11/2015 - 01/2010
2	Nphe(1)- (pF)Phe(4)- Aib(7)- Arg(14)- Lys(15)- nociceptin-amideIBA 11/2015 - 01/2010
2	Opioid Peptides (Opioid Peptide)IBA 11/2015 - 01/2002
2	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 08/2011
2	fluorescein isothiocyanate bovine serum albuminIBA 01/2013 - 11/2007
2	Prion ProteinsIBA 08/2012 - 09/2005
2	2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA 07/2004 - 12/2002
2	delta Opioid Receptors (delta Opioid Receptor)IBA 07/2004 - 12/2002
2	AcidsIBA 12/2002 - 01/2002
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	Sildenafil Citrate (Viagra)FDA Link 01/2022
1	Tadalafil (Cialis)FDA Link 01/2022
1	Vardenafil Dihydrochloride (Levitra)FDA Link 01/2022
1	diethylstilbestrol monophosphate (PDES)IBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2021
1	Protein Subunit VaccinesIBA 05/2021
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 05/2021
1	Antitussive Agents (Antitussives)FDA Link 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Fetal Hemoglobin (Hemoglobin F)IBA 10/2020
1	GlobinsIBA 10/2020
1	Small Molecule LibrariesIBA 10/2020
1	Fluorouracil (Carac)FDA LinkGeneric 09/2019
1	Cyclic PeptidesIBA 09/2019
1	ZP120IBA 01/2019
1	Explosive Agents (Explosives)IBA 01/2019
1	Proline (L-Proline)FDA Link 01/2018
1	Nootropic Agents (Nootropics)IBA 03/2017
1	hemopressinIBA 11/2016
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2016
1	CannabinoidsIBA 11/2016
1	Hemoglobins (Hemoglobin)IBA 11/2016
1	Immunologic Factors (Immunomodulators)IBA 04/2016
1	Bronchodilator Agents (Bronchodilators)IBA 04/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2015

Therapy/Procedure

3	Therapeutics 08/2011 - 12/2004
1	Intravesical Administration 01/2019